Last updated on March 2017

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).


Brief description of study

A Randomized, double-blind, parallel-group, 12-week, chronic-dosing, multi-center study to assess the efficacy and safety of PT010 compared to PT009 in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD).

Detailed Study Description

This study is comparing a fixed-dose Triple combination product to a fixed-dose dual combination product. The study is for a 12-week duration. We are also including an option for a 24-hour Holter Monitoring as a sub-study to the main study.

Clinical Study Identifier: TX147806

Find a site near you

Start Over

Midwest Chest Consultants

330 First Capitol Drive, Suite 470 St. Charles, MO USA
  Connect »